The talk of the show?23 Oct 2019
Outsourcing, biologics, generics and patient compliance look set to get tongues wagging at this year's CPhI WW.
Ahead of CPhI Worldwide in Frankfurt next week, Barbara Morgan, Pharmaceutical Business Director at Lubrizol Life Science Health discusses the trends she expects to be the talk of the show.
What do you think will be the major trends and talking points at CPhI Worldwide 2019?
We expect to see a continuation of the growing trend of outsourcing the full spectrum of pharmaceutical services, including commercial manufacturing. Recent figures show that only around one third of manufacturing — whether in the development stages or after commercial launch — is conducted in-house. This year, we have invested in our own commercial manufacturing capabilities with the opening of a new commercial manufacturing facility which is now up and running and recently produced its first set of three registration batches.
The ongoing growth of the biologics market over the past few years will likely be reflected on the show floor, particularly as 2019 has witnessed the FDA releasing guidelines on how biosimilars can achieve an interchangeable status and substitute the reference biologic without a prescriber intervening.
There has also been much discussion this year about the pricing pressures on generics, with regulators, patients and politicians seeking to drive down prices.
In terms of drug development trends, we expect to see an increased focus on long-acting products such as microparticle depots and implants as drug developers seek dosage forms that can aid better patient compliance. This is a topic we are keen to discuss with visitors to our stand.
What is your company hoping to achieve at this year's event?
This year we’re hoping to engage in discussions that center around GMP for clinical trial supply and commercial manufacturing. Lubrizol Life Science Health is currently well known for its focus on complex drug development projects. We’re keen to expand our client base and engage with those who are not yet familiar with our unique capabilities around commercial manufacturing of small batch size products.
What do you most look forward to about CPhI?
I enjoy how well-organized and efficient the CPhI Worldwide event is and the fact that it brings so many people in the industry together, giving you an opportunity to catch up with those clients that you don’t often see in person. It also provides a great environment for meeting new clients and prospects and learning more about the latest trends and talking points in the industry among like-minded peers.
Any presentations/events or news you'd like to tell us about?
This year our big announcement is that we will be changing our name from Particle Sciences to Lubrizol Life Science Health. The name change is an outward sign of our official transition under the Lubrizol Life Science brand umbrella.
As part of Lubrizol Life Science, we can share and draw upon the resources that come with being part of a large corporation, providing customers with greater support and market insights that help them meet their goals.
The game is on for connected devices
20 Feb 2020
Global biologics markets, delivery device innovation and smart packaging ‘unpacking’ new growth opportunities for pharma.Read more
CPhI South East Asia rescheduled for July 2020
18 Feb 2020
Event move ensures extra precautions and safety measures takenRead more
Report predicts booming ASEAN generics export market for 2020
13 Feb 2020
The changing opportunities are attributed to rising GMP standards and increased regional harmonization.Read more
Innovation awarded at Pharmapack
10 Feb 2020
Innovations across primary and secondary packaging, drug delivery devices, and machinery acknowledged in Exhibitor Innovations, with Health Product Awards for patient-centricity and eco-design.Read more
Digital value-added medicines - a key driver for 2020
29 Jan 2020
Pharmapack also identifies waste management and the use of blockchain as key trends for the year ahead.Read more
CPhI and AAPS partner to expand expert scientific content at CPhI North America
10 Jan 2020
CPhI and the American Association of Pharmaceutical Scientists (AAPS) today announced a partnership to expand the scientific content of activities sponsored by CPhI, including CPhI North America—the only event to bring the entire North American pharmac...Read more
Innovation and regulatory harmonisation to drive Indian pharma in 2020
18 Dec 2019
Experts suggest the continued goal of aligning India to Western regulatory standards will help the country sustain significant increases in exports.Read more
Connectivity, customization and sustainability driving packaging and drug delivery in 2020
4 Dec 2019
Pharmapack 2020 gathering top specialists and pioneers to exchange their vision on best strategies to tackle key challenges.Read more
Worldwide event predicts global pharma trends for 2020
27 Nov 2019
Content sessions identify value-added medicines, preventive drugs, early diagnostics and patient experience as some of the trends for the year ahead.Read more
India pharma forecast to grow strongly in 2020
22 Nov 2019
The rise in exports growth potential is believed to be in response to concerted reforms by the CDSCO and industry quality improvements in the last few years.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation